Related Experiment Video
Updated: Apr 26, 2026

Collection of Serum- and Feeder-free Mouse Embryonic Stem Cell-conditioned Medium for a Cell-free Approach
Published on: January 8, 2017
The impracticality of biomedical rejuvenation therapies: translational and pharmacological barriers
1ELPIs Foundation for Indefinite Lifespans , London, United Kingdom .
Abstract:
The notion that it is possible to eradicate age-related degeneration and live a life with a negligible rate of senescence solely by using a physical "repair-oriented" approach is flawed on a number of fronts. Here, I will argue that there are so many unknown variables embedded in this line of thinking that make the final result impossible to predict. Two relatively easy-to-research areas are the search for successful cross-link breakers and an effective lysosomal degradation therapy. A more complex and speculative strategy is whole-body interdiction of lengthening of telomeres (WILT). Highlighting these as examples, I argue that it is unlikely that such rejuvenation biotechnologies will be used meaningfully by the general public. The discussion assumes that although such therapies may in theory one day be developed in the laboratory, and even possibly be formulated as physical clinical therapies, these will be unusable in practical terms when applied upon humans at large. Due to inherent characteristics of our biological, evolutionary, and psychological heritage, it is implausible that curing aging will occur by using physical interventions alone.
Insights
Physical interventions alone are unlikely to cure aging. Complex biological, evolutionary, and psychological factors mean that even developed rejuvenation therapies may not be practically usable for the general public.
Area of Science:
- Biogerontology
- Biotechnology
- Longevity Science
Background:
- The concept of eradicating age-related degeneration through physical repair is a prominent area of research.
- However, this approach faces significant challenges due to numerous unknown variables.
Purpose of the Study:
- To critically evaluate the feasibility of physical interventions for aging.
- To explore the potential limitations of developing and implementing rejuvenation biotechnologies.
Main Methods:
- Discussion of specific examples: cross-link breakers, lysosomal degradation therapy, and whole-body interdiction of lengthening of telomeres (WILT).
- Analysis of theoretical biotechnological advancements versus practical human application.
Main Results:
- The search for effective cross-link breakers and lysosomal degradation therapies presents research challenges.
- Whole-body interdiction of lengthening of telomeres (WILT) is a more speculative strategy.
- Even if developed, these therapies may be unusable by the general public.
Conclusions:
- Physical interventions alone are insufficient to cure aging.
- Biological, evolutionary, and psychological factors limit the practical application of rejuvenation biotechnologies.
- A comprehensive approach beyond physical repair is necessary to address aging.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
07:39SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Related Concept Videos
Microorganisms in Medicine and Therapeutics
iPS Cell Differentiation
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Somatic to iPS Cell Reprogramming
Drug Biotransformation: Overview